Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
Andrew Bivard(Hunter Medical Research Institute), Mark Parsons(UNSW Sydney), Geoffrey Cloud(Monash University), Angelos Sharobeam(The University of Melbourne), Leonid Churilov(The University of Melbourne), Nawaf Yassi, Bernard Yan(Centre hospitalier universitaire d'Orléans), Henry Zhao(Monash University), Tissa Wijeratne(Sunshine Hospital), Francesca Langenberg(The Royal Melbourne Hospital), Angela Dos Santos(Ambulance Victoria), Geoffrey A. Donnan(The Royal Melbourne Hospital), Michael Valente(The University of Melbourne), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Steve Bernard(Ambulance Victoria), Karen Smith(University of North Carolina at Chapel Hill), Philip Choi, Skye Coote(The Royal Melbourne Hospital), Henry Ma(Monash University), Anna Balabanski(Ambulance Victoria), Felix Ng(Capital Medical University), Michael Stephenson(Ambulance Victoria), Liudmyla Olenko(The University of Melbourne), Bruce Campbell(The Royal Melbourne Hospital), Stephen M. Davis(The Royal Melbourne Hospital), Chushuang Chen(Liverpool Hospital)
Cited by 8
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
Ischaemic stroke
|Nature Reviews Disease Primers|2019|1.7k